BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30651262)

  • 1. Atrial fibrillation.
    Guha K
    Clin Med (Lond); 2019 Jan; 19(1):90. PubMed ID: 30651262
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of thromboembolism in patients developing critical illness-associated atrial fibrillation.
    Clayton B; Ball S; Read J; Waddy S
    Clin Med (Lond); 2018 Aug; 18(4):282-287. PubMed ID: 30072549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response.
    Clayton B
    Clin Med (Lond); 2019 Jan; 19(1):90. PubMed ID: 30651263
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thromboembolism risks in atrial fibrillation].
    Babuty D; Gorin L; Zannad N; Fauchier L
    Ann Cardiol Angeiol (Paris); 2009 Dec; 58 Suppl 1():S11-3. PubMed ID: 20103170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of arterial thromboembolism location with presence of nonvalvular atrial fibrillation.
    Kızıltan F; Benli ED; Yılmaz S; Kalender M; Gunaydin S
    Vascular; 2020 Jun; 28(3):325-328. PubMed ID: 32036773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study.
    Overvad TF; Skjøth F; Lip GY; Lane DA; Albertsen IE; Rasmussen LH; Larsen TB
    Stroke; 2015 Aug; 46(8):2168-74. PubMed ID: 26152296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of thromboembolism in patients with atrial fibrillation].
    Veselka J; Bartůnĕk P
    Vnitr Lek; 1996 Nov; 42(11):792-5. PubMed ID: 9012126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation?
    Overvad TF; Skjøth F; Albertsen IE; Larsen TB; Søgaard M; Lip GYH
    Am J Med; 2021 Jan; 134(1):67-75.e5. PubMed ID: 32634387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation and anticoagulation in patients with breast cancer.
    D'Souza M; Smedegaard L; Madelaire C; Bang C; Nielsen D; Torp-Pedersen C; Gislason G; Schou M; Fosbøl E
    Scand Cardiovasc J; 2019 Oct; 53(5):247-254. PubMed ID: 31251080
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study.
    Fangel MV; Nielsen PB; Kristensen JK; Larsen TB; Overvad TF; Lip GYH; Jensen MB
    Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007030. PubMed ID: 30995869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study.
    Fangel MV; Nielsen PB; Larsen TB; Christensen B; Overvad TF; Lip GYH; Goldhaber SZ; Jensen MB
    Int J Cardiol; 2018 Oct; 268():137-142. PubMed ID: 30041778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Clementy N; Haguenoer K; Fauchier L; Lip GY
    Am J Med; 2014 Oct; 127(10):972-8. PubMed ID: 24929021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours.
    Weigner MJ; Caulfield TA; Danias PG; Silverman DI; Manning WJ
    Ann Intern Med; 1997 Apr; 126(8):615-20. PubMed ID: 9103128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk].
    Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.
    Middlekauff HR; Stevenson WG; Gornbein JA
    Arch Intern Med; 1995 May; 155(9):913-20. PubMed ID: 7726699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators.
    Ann Intern Med; 1992 Jan; 116(1):6-12. PubMed ID: 1727097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators.
    Ann Intern Med; 1992 Jan; 116(1):1-5. PubMed ID: 1727091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we administrate anticoagulants to critically ill patients with new onset supraventricular arrhythmias?
    Labbé V; Ederhy S; Fartoukh M; Cohen A
    Arch Cardiovasc Dis; 2015 Apr; 108(4):217-9. PubMed ID: 25858533
    [No Abstract]   [Full Text] [Related]  

  • 19. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation.
    Kamel H; Okin PM; Longstreth WT; Elkind MS; Soliman EZ
    Future Cardiol; 2015 May; 11(3):323-31. PubMed ID: 26021638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolism in Atrial Fibrillation: Role of the Left Atrial Appendage.
    Safavi-Naeini P; Rasekh A
    Card Electrophysiol Clin; 2020 Mar; 12(1):13-20. PubMed ID: 32067643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.